The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barre syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency’s website showed on Thursday. Medicines and Healthcare products Regulatory Agency’s (MHRA) decision comes after the European medicines agency added GBS as a …
Read More »AstraZeneca finds no evidence of increased blood clot risk from vaccine, Health News, ET HealthWorld
LONDON: AstraZeneca said on Sunday a review of safety data of people vaccinated with its Covid-19 vaccine has shown no evidence of an increased risk of blood clots. AstraZeneca’s review, which covered more than 17 million people vaccinated in the United Kingdom and European Union, comes after health authorities in …
Read More »